DEF 14AThe Ballot
Theravance Biopharma, Inc. files DEF 14A
Filed Mar 21, 2018 · 8y ago · Accession 0001047469-18-001961
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Theravance Biopharma, Inc.
- Ticker
- TBPH
- CIK
- 1583107
- Form type
- DEF 14A
- Filing date
- Mar 21, 2018
- Report date
- May 1, 2018
- Document
- a2234945zdef14a.htm
- Size
- 1.2 MB